Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hunter Moyer

Plastic Surgery Rapid City, SD Medical Doctor

NPI 1992989487 CMS profile 181449

2805 5Th St, Rapid City, SD 57701

Open in the dashboard

General payments

$9,330

124 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hunter Moyer of Rapid City, SD is reported in the CMS Open Payments database as having received $9,330 across 124 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,569 22
2024 General $313 11
2023 General $2,910 19
2022 General $2,261 24
2021 General $367 17
2020 General $344 13
2019 General $566 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hunter Moyer
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Hunter Moyer were reported at $2,569. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Hunter Moyer Plastic Surgery median Middle half National median
2019 $566 $371 $122–$1,483 $163
2020 $344 $158 $52–$438 $114
2021 $367 $249 $87–$752 $132
2022 $2,261 $274 $102–$793 $149
2023 $2,910 $299 $113–$891 $160
2024 $313 $361 $124–$1,062 $164
2025 $2,569 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $4,471 21 payments
  2. Surgical Innovation Associates, Inc. $1,090 1 payment
  3. Smith+Nephew, Inc. $869 44 payments
  4. Stryker Corporation $730 5 payments
  5. Sientra, Inc. $546 5 payments
  6. Davol Inc. $455 4 payments
  7. Mentor Worldwide LLC $443 16 payments
  8. Innovation Technologies Inc $124 5 payments
  9. Allergan Inc. $114 7 payments
  10. Pacira Pharmaceuticals Incorporated $99 1 payment
  11. Other $390 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $4,395 6 payments
  2. Food and Beverage $3,834 116 payments
  3. Long term medical supply or device loan $1,090 1 payment
  4. Education $10 1 payment
Products named General payments · program years 2019–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS $4,335 19 payments
  2. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $2,160 8 payments
  3. REVOLVE $2,123 7 payments
  4. DuraSorb Monofilament Mesh $1,090 1 payment
  5. 1688 $616 2 payments
  6. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $546 5 payments
  7. MENTOR MemoryGel Resterilizable Gel Sizer $381 13 payments
  8. PICO $209 5 payments
  9. Stravix $189 9 payments
  10. STRAVIX MESH $153 2 payments
  11. Other $2,829 114 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$40,958

Medicare's payments for the services billed

Medicare patients

61

Average age 69

Services billed

202

46 women, 15 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Cancer 57%
Arthritis 52%
Depression 36%
Diabetes 33%
Osteoporosis 25%
Ischemic heart disease 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

124 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record